Economic evaluation of strategies against coronavirus: a systematic review
- PMID: 36933043
- PMCID: PMC10024293
- DOI: 10.1186/s13561-023-00430-1
Economic evaluation of strategies against coronavirus: a systematic review
Abstract
Background: The COVID-19 outbreak was defined as a pandemic on 11 March 2020 by the World Health Organization. After that, COVID-19 has enormously influenced health systems around the world, and it has claimed more than 4.2 million deaths until July 2021. The pandemic has led to global health, social and economic costs. This situation has prompted a crucial search for beneficial interventions and treatments, but little is known about their monetary value. This study is aimed at systematically reviewing the articles conducted on the economic evaluation of preventive, control and treatment strategies against COVID-19.
Material and method: We searched PubMed, Web of Science, Scopus, and Google Scholar from December 2019 to October 2021 to find applicable literature to the economic evaluation of strategies against COVID-19. Two researchers screened potentially eligible titles and abstracts. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist was used to quality assessment of studies.
Results: Thirty-six studies were included in this review, and the average CHEERS score was 72. Cost-effectiveness analysis was the most common type of economic evaluation, used in 21 studies. And the quality-adjusted life year (QALY) was the main outcome applied to measure the effectiveness of interventions, which was used in 19 studies. In addition, articles were reported a wide range of incremental cost-effectiveness ratio (ICER), and the lowest cost per QALY ($321.14) was related to the use of vaccines.
Conclusion: Based on the results of this systematic review, it seems that all strategies are likely to be more cost-effective against COVID-19 than no intervention and vaccination was the most cost-effective strategy. This research provides insight for decision makers in choosing optimal interventions against the next waves of the current pandemic and possible future pandemics.
Keywords: COVID-19; Cost analysis; Economic evaluation; Iran; Strategy.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Economic evaluation of programs against COVID-19: A systematic review.Int J Surg. 2021 Jan;85:10-18. doi: 10.1016/j.ijsu.2020.11.015. Epub 2020 Nov 21. Int J Surg. 2021. PMID: 33227532 Free PMC article.
-
Health economic evaluation of preventive digital public health interventions using decision-analytic modelling: a systematized review.BMC Health Serv Res. 2023 Mar 17;23(1):268. doi: 10.1186/s12913-023-09280-3. BMC Health Serv Res. 2023. PMID: 36932436 Free PMC article. Review.
-
Economic evaluation of COVID-19 vaccination: A systematic review.J Glob Health. 2023 Jan 14;13:06001. doi: 10.7189/jogh.13.06001. J Glob Health. 2023. PMID: 36637810 Free PMC article.
-
Cost-effectiveness of Evolocumab in Cardiovascular Disease: A Systematic Review.Curr Ther Res Clin Exp. 2024 Sep 1;101:100758. doi: 10.1016/j.curtheres.2024.100758. eCollection 2024. Curr Ther Res Clin Exp. 2024. PMID: 39469092 Free PMC article. Review.
-
Economic evaluation of vaccination against COVID-19: A systematic review.Health Sci Rep. 2024 Feb 7;7(2):e1871. doi: 10.1002/hsr2.1871. eCollection 2024 Feb. Health Sci Rep. 2024. PMID: 38332928 Free PMC article.
Cited by
-
The Role and Value of Professional Rapid Testing of Acute Respiratory Infections (ARIs) in Europe: A Special Focus on the Czech Republic, Poland, and Romania.Diagnostics (Basel). 2024 Mar 16;14(6):631. doi: 10.3390/diagnostics14060631. Diagnostics (Basel). 2024. PMID: 38535051 Free PMC article. Review.
-
Masks and respirators for prevention of respiratory infections: a state of the science review.Clin Microbiol Rev. 2024 Jun 13;37(2):e0012423. doi: 10.1128/cmr.00124-23. Epub 2024 May 22. Clin Microbiol Rev. 2024. PMID: 38775460 Free PMC article. Review.
-
Cost-effectiveness of mask mandates on subways to prevent SARS-CoV-2 transmission in the United States.PLoS One. 2024 May 15;19(5):e0302199. doi: 10.1371/journal.pone.0302199. eCollection 2024. PLoS One. 2024. PMID: 38748706 Free PMC article.
-
Factors affecting the acceptance of tele-psychiatry: a scoping study.Arch Public Health. 2023 Jul 13;81(1):131. doi: 10.1186/s13690-023-01146-8. Arch Public Health. 2023. PMID: 37443137 Free PMC article.
-
Cost-effectiveness analysis of COVID-19 booster doses and oral antivirals: Case studies in the Indo-Pacific.PLoS One. 2024 Sep 30;19(9):e0294091. doi: 10.1371/journal.pone.0294091. eCollection 2024. PLoS One. 2024. PMID: 39348348 Free PMC article.
References
-
- Bartsch SM, Ferguson MC, McKinnell JA, O’shea KJ, Wedlock PT, Siegmund SS, et al. The potential health care costs and resource use associated with COVID-19 In the United States: a simulation estimate of the direct medical costs and health care resource use associated with COVID-19 infections in the United States. Health Aff. 2020;39(6):927–35. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources